Apollo Medicine

: 2022  |  Volume : 19  |  Issue : 3  |  Page : 135--136

Innovations in cardiovascular sciences – A roadmap toward new standardization in cardiovascular treatment

NN Khanna 
 Senior Consultant Interventional Cardiology, & Vascular Interventions, Indraprastha Apollo Hospital, New Delhi & Advisor Apollo Group of Hospitals, Chairman Asia Pacific Vascular Society, President International Society of Endovascular Specialist ( INDIAN CHAPTER) New Delhi, India

Correspondence Address:
N N Khanna
Indraprastha Apollo Hospitals, New Delhi - 110 076

How to cite this article:
Khanna N N. Innovations in cardiovascular sciences – A roadmap toward new standardization in cardiovascular treatment.Apollo Med 2022;19:135-136

How to cite this URL:
Khanna N N. Innovations in cardiovascular sciences – A roadmap toward new standardization in cardiovascular treatment. Apollo Med [serial online] 2022 [cited 2023 Jan 31 ];19:135-136
Available from: https://apollomedicine.org/text.asp?2022/19/3/135/353465

Full Text

The last 2 years have passed in dealing with a new health-care challenge in the world - THE COVID-19 Pandemic and its complications. The entire world was caught unaware and was initially not ready to face this enormous challenge because of a lack of knowledge about the epidemiology of this novel virus and the exact treatment strategies, prevention, and long-term complications. However, the medical fraternity and health-care industry reacted robustly and rose up to the occasion and fought back, defeating the pandemic by quick manufacturing of vaccines (using the conventional and messenger RNA technology), following the virus mutation and tracking the infection. Health authorities across countries, along political and professional lines, joined hands to mass vaccinate and quickly achieve a good amount of herd immunity to tame this pandemic. It gained knowledge about mutant variants of the virus and learned to deal with late complications of COVID-19 infection, especially cardiovascular complications, which are often life-threatening. The selfless service, devotion, and agility of health-care warriors need our salute and should never be forgotten in the history of medicine.

Various cardiovascular manifestations of COVID-19, especially acute coronary syndrome, myocarditis, cardiomyopathy, and venous thromboembolism have been discussed in this special issue of Apollo Medicine, which focuses on cardiac sciences.

The last decade has seen revolutionary and game-changing advancements and technologies for treating cardiac and vascular diseases. The emphasis on cardiac care across the world has shifted from open surgeries to a pinhole or percutaneous procedures that require a very short stay in hospital. It is now routine practice to discharge patients after complex coronary, peripheral vascular, and endovascular interventions on the same day or within 24–48 h.

Endovascular repair of complex aortic aneurysms/dissections (EVAR), TAVI, Mitral Clip, Subintimal Endovascular Revascularization of critical limb ischemia, and endovascular treatment of massive pulmonary embolism has come up as a novel, minimally invasive and safe alternative to surgery. It has brought new hope to patients with severe comorbidities and advanced age, avoiding the need of general anesthesia, blood transfusion, and major scar. The last decade has also seen advancements in electrophysiological procedures. Three-dimensional mapping has helped in radiofrequency ablation of atrial/ventricular arrhythmias, and cardiac resynchronization devices have resulted in significant improvement of the left ventricular dysfunction.

Pharmacological discoveries also have not lacked behind, especially the discovery of SGLT-2 inhibitors and ARNI. They have tremendously and positively influenced the treatment and survival of patients with congestive heart failure. In ischemic cardiovascular disease, the concept is changing from dual antiplatelet therapy to dual pathway inhibition. The landmark trials have unequivocally proved the superiority of these drugs and approaches in significantly reducing mortality, stroke, Myocardial infarction, and amputation.

In this issue, there is an interesting discussion on the management of calcium in coronary arteries, complex coronary interventions in elderly patients, and how sepsis can lead to suicidal left ventricle dysfunction in patients with hypertrophic cardiomyopathy.

In this changing scenario of medicine, the world is seeing hope and rekindling the passion for research, innovation, and service in the medical fraternity. This issue focuses on various advancements in cardiac sciences.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.